Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Leukemia & Lymphoma|September 29, 2015
A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trialSung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2026
Selinexor Plus Ruxolitinib in JAK Inhibitor-Naïve Myelofibrosis: Phase 3 SENTRY TrialPrithviraj Bose, Haris Ali, Haifa Kathrin Al-Ali, et al.
Blood Research|February 25, 2021
Updated recommendations for the treatment of venous thromboembolismJunshik Hong, Seo-Yeon Ahn, Yoo Jin Lee, et al.
Blood Research|June 30, 2021
Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicityJunshik Hong, Yoo Jin Lee, Sung Hwa Bae, et al.
Biomed Research International|July 5, 2014
Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in KoreaHo Sup Lee, Kihyun Kim, Dok Hyun Yoon, et al.
Plos One|November 9, 2016
Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic SyndromeKoung Jin Suh, June-Won Cheong, Inho Kim, et al.
Leukemia & Lymphoma|July 22, 2014
Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of LymphomaGyeong-Won Lee, Se-Il Go, Seok-Hyun Kim, et al.
The Journal of Clinical Investigation|December 7, 2023
PD-1H/VISTA mediates immune evasion in acute myeloid leukemiaTae Kon Kim, Xue Han, Qianni Hu, et al.
Leukemia Research|July 12, 2025
Phase 1 first-in-human dose-expansion study of the oral SF3B1 modulator H3B‑8800 in lower-risk myelodysplastic syndromeJames M Foran, Guillermo F Sanz, Justin M Watts, et al.
The Journal of Clinical Investigation|November 15, 2023
LAIR-1 agonism as a therapy for acute myeloid leukemiaRustin R Lovewell, Junshik Hong, Subhadip Kundu, et al.
Pageof 18